AK112

Clinical trials for AK112 explained in plain language.

Never miss a new study

Get alerted when new AK112 trials appear

Sign up with your email to follow new studies for AK112, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New combo aims to shrink rectal tumors, help patients skip surgery

Disease control Not yet recruiting

This study is testing a two-part treatment for a specific type of rectal cancer. First, patients receive a short, intense course of radiation. Then, they receive an immunotherapy drug called AK112. The main goal is to see if this combination can completely eliminate the tumor, po…

Matched conditions: AK112

Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control

Last updated Mar 17, 2026 12:55 UTC

AK112

Get alerted when new AK112 trials appear

New combo aims to shrink rectal tumors, help patients skip surgery